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Abstract
We asked whether the likelihood for mice of the C57BL/6J strain to develop glucose intolerance
when fed a high-fat diet is related to the increase in circulating levels of leptin or free fatty acids
(FFA). We therefore administered a high-fat diet (58% fat) or a control diet (11% fat) for 1.5 years.
NMRI mice were used as a more glucose-tolerant control group. After a high-fat diet, the area under
the glucose curve following an intraperitoneal glucose challenge (1 g/kg) increased more markedly in
C57BL/6J mice (by 42 6 8%) than in NMRI mice (by 21 6 3%, P ¼ 0.007). Plasma levels of insulin,
leptin and FFA increased in both strains of mice, whereas plasma glucose levels were elevated after
the high-fat diet only in C57BL/6J mice. The slope of the relationship between body weight and
plasma leptin was higher in C57BL/6J mice than in NMRI mice, suggesting leptin insensitivity.
Circulating leptin correlated to circulating insulin in both strains of mice, whereas plasma FFA
correlated to plasma insulin in NMRI mice but not in C57BL/6J mice. These correlations remained
significant after adjustment for body weight. The results show that elevated leptin and FFA levels
evolve after high-fat feeding in mice, in conjunction with evolvement of glucose intolerance and
hyperglycemia.
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Introduction
Obesity is associated with insulin resistance, which is
sensed by the islet B cells causing increased insulin
secretion (1–3). The ensuing hyperinsulinemia is
usually adequate for preventing hyperglycemia. How-
ever, if the signals to stimulate insulin secretion fail, the
hyperinsulinemia might be inadequate, which could
result in glucose intolerance or diabetes. Therefore,
knowledge of the signals between insulin resistance and
insulin secretion is of importance for the understanding
of diabetes pathogenesis. To generate such knowledge,
animal models have been developed (4). One well
characterized model is the C57BL/6J mouse, which is
the background strain for the ob/ob mutation (5).
When given a high-fat diet, C57BL/6J mice develop
obesity, hyperglycemia, hyperinsulinemia and impaired
glucose-stimulated insulin secretion (6–9). The tendency
for C57BL/6J mice to develop glucose intolerance upon
feeding a high-fat diet is in contrast to other strains of
mice, for example the A/J mouse (8).
It has previously been demonstrated that circulating
levels of both leptin and lipids are increased upon high-
fat feeding of C57BL/6J mice (6, 10, 11). Whether these
responses are of importance for the compensatory
changes in islet function accompanying the high-fat
feeding or whether the responses are involved in the
development of glucose intolerance, which follows high-
fat feeding in C57BL/6J mice, is not known. In this
study, we therefore asked whether the likelihood for
C57BL/6J mice to develop glucose intolerance when fed
a high-fat diet is related to the increase in circulating
levels of leptin or free fatty acids (FFA). We gave a high-
fat diet to both C57BL/6J mice and normal NMRI mice
(which evolve only a marginal insulin resistance with a
low degree of glucose intolerance on a high-fat diet) and
analyzed plasma levels of leptin and FFA and related
these parameters to body weight and the circulating
levels of insulin and glucose.
Methods
Animals
Mice of the C57BL/6J strain or the NMRI strain were
obtained from Bomholtgaard Breeding and Research
Centre, Ry, Denmark, at 4 weeks of age. All mice were
females, to avoid the profound gender differences in
circulating leptin, which has been documented in
humans. Half of the mice in each batch received a
high-fat diet (Research Diets, N Brunswick, NJ, USA),
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whereas the other half of the animals received an
ordinary rodent chow diet (Lactamin AB, Stockholm,
Sweden). On a caloric base, the high-fat diet consisted
of 16.4% protein, 25.6% carbohydrates and 58.0% fat
(total 23.4 kJ/g), whereas the control diet consisted of
25.8% protein, 62.8% carbohydrates and 11.4% fat
(total 12.6 kJ/g). Throughout the study period, the
mice had free access to food and water. Four to five mice
were kept per cage in a temperature-controlled (22 6
1 8C) room with a 12 h light:12 h darkness cycle with
lights on at 0600 h. The experiments were undertaken
after 1.5 years on the respective diet, at a time point
where the difference in the development of obesity and
glucose intolerance in the C57BL/6J mice as compared
with NMRI mice is large and stable. The study was
approved by the Animal Ethics Committee at Lund
University.
Experiments
After 1.5 years on the respective diet, 68 non-fasted
mice (13 C57BL/6J high-fat diet, 15 C57BL/6J control
diet, 20 NMRI high-fat diet, 20 NMRI control diet)
were injected intraperitoneally (i.p.) with D-glucose
(Fluka Chemie AG, Buchs, Switzerland) at 1 g/kg. The
volume load was 10 ml/g body weight. Blood samples
were taken immediately before the glucose challenge
and after 10, 30, 60 and 120 min. After centrifugation,
plasma was stored at ¹20 8C until assayed for glucose
concentration.
Blood sampling
After 1.5 years on high-fat or control diets, a blood
sample was taken from 163 non-fasted animals (46
C57BL/6J high-fat diet, 48 C57BL/6J control diet, 34
NMRI high-fat diet, 35 NMRI control diet). The samples
were taken from the intraorbital, retrobulbar plexus for
the measurement of plasma levels of glucose, insulin,
leptin and FFA in non-fasted animals. After centrifu-
gation, plasma was stored at ¹20 8C until assayed.
Simultaneously, body weight was determined.
Analyses
Plasma leptin levels were determined with a newly
developed RIA specific for mouse leptin (10) (Linco
Research Inc., St Charles, MO, USA). The method uses
a polyclonal rabbit antibody raised against highly
purified recombinant mouse leptin, 125I-labeled tracer
prepared with recombinant mouse leptin and mouse
leptin as standard. Anti-rabbit IgG was used for
separation of bound and free leptin. Coefficients of
variations (CV) ranged from 4.0 to 11.2% within runs
and from 3.3 to 14.6% between runs. Plasma insulin
was determined radioimmunochemically with the use
of a guinea pig anti-rat insulin antibody, 125I-labelled
porcine insulin as tracer and rat insulin as standard
(Linco). Free and bound radioactivity were separated by
use of an anti-IgG (goat anti-guinea pig) antibody
(Linco). The sensitivity of the assay is 12 pmol/l and the
CV less than 3% at both low and high levels. Glucose
was determined with the glucose oxidase method, and
FFA were extracted and measured photometrically (12).
Statistics
Means 6 S.E.M. are shown. Statistical analyses were
performed with the SPSS for Windows system. Statis-
tical comparisons for the differences between high-fat
and control diet treated mice were performed by
Student’s unpaired t-test. Pearson’s product moment
correlation was used to estimate linear relationships
between variables. An insulin resistance index (IRI) was
calculated as plasma insulin · plasma glucose in each
individual mouse. This index has been verified as a
substitute for hyperinsulinemic clamp studies in
humans to quantify insulin sensitivity (13, 14) and
has recently been used as a crude estimation for insulin
sensitivity in studies in mice (15).
Results
Glucose tolerance test
The i.p. glucose tolerance test showed that in both
strains of mice, high-fat diet induced glucose intoler-
ance. Individual glucose levels were significantly higher
in high-fat diet fed at 30 and 60 min compared with the
respective control mice (Fig. 1). At 120 min after
glucose challenge, plasma glucose was still markedly
higher in high-fat diet fed C57BL/6J mice (24.9 6
3.2 mmol/l) compared with the controls (14.3 6
1.7 mmol/l, P ¼ 0.011), whereas in NMRI mice,
plasma glucose levels at 120 min were not significantly
different between the two groups. Also, the area under
the curve for glucose (AUCglucose) was increased by high-
fat diet in both strains. In C57BL/6J mice given high-fat
diet, AUCglucose was 2.5 6 0.2 mol/l · 120 min vs 1.8 6
0.2 mol/l · 120 min in mice given the control diet
(P ¼ 0.025), and the corresponding figures in NMRI
mice were 1.0 6 0.1 vs 0.8 6 0.08 mol/l · 120 min
(P < 0.008). The worsening of glucose tolerance was
more marked in C57BL/6J mice than in NMRI mice
after high-fat diet, since AUCglucose was increased by
42 6 8% in C57BL/6J mice vs by 21 6 3% in NMRI
mice (P ¼ 0.007).
Body weight and plasma levels of glucose,
insulin, leptin and FFA
High-fat diet increased body weight in both strains of
mice. Also plasma levels of insulin, leptin and FFA
increased in both strains of mice, whereas plasma
glucose levels were significantly elevated after high-fat
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diet only in C57BL/6J mice and not in NMRI mice.
Similarly, the calculated IRI was elevated in both strains
of mice (Table 1).
Correlation between body weight and plasma
leptin and insulin
There was a close correlation between body weight and
plasma leptin in both strains of mice (Fig. 2). The slope
of the relationship between body weight and leptin was
different in different subgroups of the mice. Thus, the
slope was higher in C57BL/6J mice than in NMRI mice
(P < 0.001). Furthermore, among the C57BL/6J mice,
the slope of the relationship was considerably higher in
the mice given high-fat diet than in mice given the
control diet (P < 0.001; Table 2). This resulted in a







































































































































































































































































































































































































































































































































Figure 1 Plasma levels of glucose before and after an i.p. injection
of glucose (1 g/kg) in C57BL/6J mice (upper panel) or NMRI mice
(lower panel) given high-fat diet (X) or control diet (W) for 1.5 years.
The number of animals in each group was: C57BL/6J high-fat diet
15, C57BL/6J control diet 13, NMRI high-fat diet 20, NMRI control
diet 20. Means 6 S.E.M. are shown. Asterisks indicate probability
level of random difference between the control and the high-fat diet
groups, *P < 0:05, **P < 0:01 and ***P < 0:001.
higher plasma leptin to body weight ratio in high-fat
diet fed mice than in control diet fed mice, and a
particularly high plasma leptin to body weight ratio in
high-fat diet fed C57BL/6J mice (Table 1).
Correlation between plasma leptin, plasma
insulin, insulin resistance and plasma FFA
In both strains of mice, plasma leptin correlated to
plasma insulin (C57BL/6J mice r ¼ 0.55, P < 0.001;
NMRI mice r ¼ 0.41, P ¼ 0.012) and to the IRI (C57BL/
6J mice r ¼ 0.60, P < 0.001; NMRI mice r ¼ 0.37,
P ¼ 0.002). In C57BL/6J mice, these correlations
remained significant after adjustment for the influence
of body weight, since the ratio of plasma leptin to body
weight correlated to the ratio of plasma insulin to body
weight (r ¼ 0.38, P < 0.001) as well as to the ratio of IRI
to body weight (r ¼ 0.45, P < 0.001). Similarly, plasma
leptin correlated to plasma insulin independently of
body weight also, because in a partial correlation
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Figure 2 Upper panel: relationship between
plasma leptin levels and body weight in C57BL/6J
(X) and NMRI mice (W) given high-fat diet or control
diet for 1.5 years (i.e. figures show the relationship
in all animals irrespective of diet). Lower panels:
relationship between plasma leptin levels and body
weight in C57BL/6J (left panel) and NMRI mice
(right panel) given high-fat diet (X) or control diet
(W) for 1.5 years (i.e. in respective diets in the
respective two strains). The number of animals in
each group was: C57BL/6J mice 94 (high-fat diet
46, control diet 48), NMRI mice 69 (high-fat diet 35,
control diet 34).
Table 2 Relationship between body weight and plasma levels of leptin in C57BL/6J and NMRI mice fed a high-fat
diet or a control diet for 1.5 years.
Coefficient of the relationship Slope of the relationship between
(r ) between body weight and body weight and plasma leptin
plasma leptin (ng/ml/g 6 S.E.M.)
C57BL/6J (both diets, n ¼ 94) 0.88 (P < 0:001) 3.98 6 0.22
C57BL/6J (high fat diet, n ¼ 46) 0.79 (P < 0:001) 3.06 6 0.35
C57BL/6J (control diet, n ¼ 48) 0.80 (P < 0:001) 1.18 6 0.13
NMRI (both diets, n ¼ 69) 0.64 (P < 0:001) 1.04 6 0.15
NMRI (high-fat diet, n ¼ 35) 0.55 (P ¼ 0:001) 0.75 6 0.19
NMRI (control diet, n ¼ 34) 0.41 (P ¼ 0:017) 0.45 6 0.18
P indicates probability level of the regression.
analysis these parameters correlated significantly after
controlling for the influence of body weight (r ¼ 0.41,
P < 0.001). In NMRI mice, the ratio of leptin to body
weight correlated to the ratio of plasma insulin to body
weight (r ¼ 0.30, P ¼ 0.038), but not to the ratio of IRI
to body weight (r ¼ 0.19, P ¼ 0.116). As in the case of
C57BL/6J mice, plasma leptin correlated to plasma
insulin independently of body weight also in NMRI mice
because in a partial correlation analysis these para-
meters correlated significantly after controlling for the
influence of body weight (r ¼ 0.28, P ¼ 0:045). Plasma
leptin correlated markedly to plasma FFA in C57BL/6J
mice (r ¼ 0.52, P < 0.001) but only marginally in NMRI
mice (r ¼ 0.25, P ¼ 0.049). However, after adjustment
for body weight, these correlations were not significant
(C57BL/6J mice r ¼ 0.04, P ¼ 0.687, NMRI mice
r ¼ ¹0.11, P ¼ 0.373).
Correlation between plasma FFA and insulin
resistance
In C57BL/6J mice, plasma FFA correlated to body
weight (r ¼ 0.37, P < 0.001), plasma insulin (r ¼ 0.39,
P < 0.001) and IRI (r ¼ 0.34, P ¼ 0.001). The correla-
tion between plasma FFA and IRI remained significant
after adjustment for body weight (r ¼ 0.28, P ¼ 0.039),
whereas after adjustment for body weight, the correla-
tion between plasma FFA and plasma insulin was
no longer significant. In NMRI mice, plasma FFA
correlated to plasma insulin (r ¼ 0.46, P ¼ 0.008) and
IRI (r ¼ 0.41, P ¼ 0.012), and both these correlations
remained significant after adjustment for body weight
(r ¼ 0.42, P ¼ 0.016 for insulin, r ¼ 0.44, P ¼ 0.009
for IRI).
Discussion
High-fat diet is known to induce insulin resistance in
rodents (6, 7, 16, 17). In this study, both strains of mice
examined (C57BL/6J and NMRI) developed hyperinsu-
linemia following 1.5 years of feeding a high-fat diet.
Furthermore, the IRI was increased after the high-fat
diet in both strains. Therefore, both C57BL/6J and
NMRI mice develop insulin resistance after the high-fat
diet. Both basal plasma insulin and IRI were similar in
the two strains of mice after the high-fat diet, suggesting
that a similar degree of insulin resistance had been
induced. However, the metabolic consequences of the
insulin resistance seem to differ between the two strains.
In the NMRI mice, the evolving hyperinsulinemia was
adequate for maintaining normoglycemia, since plasma
glucose levels were not increased by the high-fat diet.
In contrast, in C57BL/6J mice, a slight hyperglycemia
evolved in spite of the marked hyperinsulinemia,
indicating inadequate hyperinsulinemia. Consequently,
glucose tolerance, as judged by an i.p. glucose tolerance
test, had deteriorated more severely in the C57BL/6J
than in the NMRI mice.
This study examined whether plasma leptin and/or
FFA correlated to the different sensitivity to high-fat
diet in the two strains. Both strains of mice evolved
hyperleptinemia in response to the high-fat diet,
which confirms previous reports (10, 11). We here
also demonstrate that C57BL/6J mice exhibited a more
marked increase in plasma leptin during the 1.5 years of
feeding with the high-fat diet than NMRI mice. The
C57BL/6J mice developed a higher leptin to body weight
ratio than the NMRI mice after high-fat diet. Although
body composition was not determined in the mice, the
higher leptin to body weight ratio in C57BL/6J mice
might indicate a reduced leptin sensitivity in this strain
of mice. This confirms a previous study demonstrating
that plasma leptin in C57BL/6J mice given a high-fat
diet on a long-term basis is higher than in another
strain of mice being not as glucose intolerant (11). This
suggests that mice developing the most marked glucose
intolerance on the high-fat diet also exhibit the lowest
leptin sensitivity.
We found that in both C57BL/6J and NMRI mice,
plasma leptin correlated to plasma insulin. This is a well
known relationship in both mice (10) and humans (18,
19). Such a correlation might be explained by insulin
stimulating leptin production, which is known as a
phenomenon executed at the adipocyte level (20).
However, it might also be suggested that leptin
stimulates insulin secretion, and therefore supports
the hyperinsulinemia in insulin resistance. Previously
observed correlations between plasma leptin and indices
of insulin secretion are suggestive of this notion (18,
21), as are studies demonstrating that leptin stimulates
insulin secretion from insulin-producing cells (22, 23).
This topic is controversial, however, since most studies
have demonstrated an inhibition by leptin of insulin
secretion (24–26). We found that plasma leptin
correlated to IRI in both strains of mice. In the
C57BL/6J mice, this relationship was independent of
body weight. Previous studies in humans on the
relationship between circulating leptin and insulin
sensitivity have not been consistent, probably due to
different groups of subjects under study (18, 27, 28).
FFA have been suggested to be involved in the
mediation of hyperinsulinemia in insulin resistance,
since plasma levels of FFA are increased in obesity (29)
and FFA are known to stimulate insulin secretion (30).
Following a long-term stimulation of the B cells,
lipotoxicity might evolve, inhibiting insulin secretion
(3). This might cause islet dysfunction and impaired
glucose tolerance. Our present results support such a
notion, since plasma FFA correlated to insulin after
adjustment for body weight in NMRI mice but not in
C57BL/6J mice. This would suggest that FFA support
insulin secretion in NMRI mice whereas in C57BL/6J
mice, FFA failed to adequately support insulin secretion
yielding inadequate hyperinsulinemia, which was then
followed by hyperglycemia and glucose intolerance. The
slight hyperglycemia then further increases plasma
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insulin, explaining why C57BL/6J mice did not have
lower plasma insulin than NMRI mice. The results
therefore suggest that the lipotoxicity (illustrated by
the lack of correlation between plasma FFA and insulin
in C57BL/6J mice) prevents the degree of hyperinsulin-
emia which is required for maintaining normoglycemia.
Since at the same time, C57BL/6J mice seemed to be
leptin resistant, it is tempting to speculate that a
function of leptin is to counteract the lipotoxic action
of FFA, which is a hypothesis in line with recent
suggestions by Unger (3). This would mean that in
NMRI mice, leptin might have prevented the lipotoxic
action of FFA allowing normoglycemia to persist,
whereas in C57BL/6J mice leptin fails to do this due to
leptin resistance. In line with this hypothesis, a recent
study using hyperleptinemic rats has shown that
chronically elevating plasma leptin increases insulin
secretion and proinsulin synthesis in obese rats (15).
In both strains of mice there was a relationship
between plasma leptin and plasma FFA. However, after
adjustment for body weight, no significant correlations
were evident between these parameters, indicating that
they both increased due to the increase in body weight.
A previous study has also failed to detect any direct
relationship between circulating leptin and FFA (31).
This study has focused on the long-term effects of a
high-fat diet. It is impossible to establish the mechanism
underlying the induction of insulin resistance from the
results of this study, since hyperinsulinemia and
hyperglycemia, i.e. signs of insulin resistance, occur
very early after introducing a high-fat diet (6). Both
leptin and FFA might be the mediators, since it has been
shown that FFA inhibit glucose oxidation and glycolysis
(32, 33) and leptin has been shown to counteract the
action of insulin (34, 35). However, the potential role
of leptin in this regard is not yet resolved, since leptin
also has been demonstrated to augment insulin action
(34, 36).
In conclusion, this study has shown that 1.5 years of
high-fat diet increases plasma leptin and FFA in two
different strains of mice. Furthermore, the high-fat diet
results in a more pronounced glucose intolerance in one
strain, C57BL/6J, than in another, NMRI. This differ-
ence is accompanied by a slight hyperglycemia in
C57BL/6J mice, which is not seen in NMRI mice. The
marked impairment of glucose tolerance in C57BL/6J
mice is accompanied by a higher plasma leptin in
relation to body weight, a sign of leptin resistance.
Furthermore, in glucose-intolerance prone C57BL/6J
mice, FFA did not correlate to basal insulin, whereas in
NMRI mice, such a correlation was significant. The
results are in line with a hypothesis that in insulin
resistance, plasma FFA stimulate insulin secretion to
support the hyperinsulinemia for the avoidance of
hyperglycemia, and that leptin counteracts the long-
term development of lipotoxicity. Consequently, if leptin
resistance evolves, the lipotoxic action of FFA becomes
unopposed, and glucose intolerance evolves.
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